Raymond James & Associates Raises Position in Exponent, Inc. (NASDAQ:EXPO)

Raymond James & Associates increased its holdings in Exponent, Inc. (NASDAQ:EXPO) by 4.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 487,035 shares of the business services provider’s stock after purchasing an additional 19,051 shares during the period. Raymond James & Associates owned 0.96% of Exponent worth $46,327,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in EXPO. Norges Bank purchased a new stake in shares of Exponent during the 4th quarter valued at $45,786,000. Bamco Inc. NY purchased a new position in shares of Exponent in the 1st quarter worth about $25,904,000. Vanguard Group Inc. lifted its stake in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after purchasing an additional 291,047 shares in the last quarter. Public Employees Retirement Association of Colorado raised its holdings in Exponent by 1,383.4% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 261,007 shares of the business services provider’s stock valued at $22,979,000 after buying an additional 243,412 shares during the period. Finally, Conestoga Capital Advisors LLC raised its stake in shares of Exponent by 9.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,687,351 shares of the business services provider’s stock valued at $222,217,000 after acquiring an additional 236,050 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Price Performance

Shares of EXPO stock opened at $105.26 on Monday. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $108.80. The firm has a market capitalization of $5.34 billion, a price-to-earnings ratio of 53.16 and a beta of 0.65. The business has a 50 day simple moving average of $99.83 and a 200 day simple moving average of $89.92.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.50 by $0.07. The firm had revenue of $132.43 million for the quarter, compared to analysts’ expectations of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. Exponent’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company earned $0.50 EPS. On average, equities analysts anticipate that Exponent, Inc. will post 2.04 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Shareholders of record on Friday, September 6th will be given a $0.28 dividend. The ex-dividend date is Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a yield of 1.06%. Exponent’s dividend payout ratio (DPR) is 56.57%.

Analyst Ratings Changes

Separately, Truist Financial restated a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Insiders Place Their Bets

In other news, VP John Pye sold 3,956 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total transaction of $415,380.00. Following the completion of the transaction, the vice president now owns 28,422 shares in the company, valued at approximately $2,984,310. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Paul R. Johnston sold 7,000 shares of Exponent stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $93.95, for a total transaction of $657,650.00. Following the completion of the transaction, the director now owns 79,236 shares in the company, valued at approximately $7,444,222.20. The disclosure for this sale can be found here. Insiders sold 44,956 shares of company stock worth $4,292,210 over the last ninety days. Company insiders own 2.10% of the company’s stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.